About Vivotecnia
Vivotecnia is a company based in Tres Cantos (Spain) founded in 2002 was acquired by Clave in June 2007.. Vivotecnia offers products and services including Toxicology Services, Biocides Testing, Cosmetics Safety Assessment, and Medical Device Testing. Vivotecnia operates in a competitive market with competitors including TransCure bioServices, GenOway, PsychoGenics, PharmaLegacy Laboratories and InVivo Biosystems, among others.
- Headquarter Tres Cantos, Spain
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$536.8 K (USD), Grant
Oct 01, 2017
-
Investors
European Union
& 2 more
-
Employee Count
Employee Count
-
Acquired by
Clave
(Jun 08, 2007)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Vivotecnia
Vivotecnia offers a comprehensive portfolio of products and services, including Toxicology Services, Biocides Testing, Cosmetics Safety Assessment, and Medical Device Testing. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Preclinical toxicology testing for safety and regulatory needs
Services for EU BPR-compliant biocidal product authorization
Safety tests for cosmetics and ingredients compliance
Evaluation per ISO 10993 for device safety
Funding Insights of Vivotecnia
- Total Funding Total Funding
- Total Rounds 1
- Last Round Grant — $536,799
-
First Round
First Round
(01 Oct 2017)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2017 | Amount | Grant - Vivotecnia | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Vivotecnia
Vivotecnia has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, Clave and Mobius Corporate Venture Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Clave is engaged in venture capital investments and management.
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Vivotecnia
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Vivotecnia
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Vivotecnia Comparisons
Competitors of Vivotecnia
Vivotecnia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TransCure bioServices, GenOway, PsychoGenics, PharmaLegacy Laboratories and InVivo Biosystems, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Humanized mouse models are developed for preclinical immune drug studies.
|
|
| domain | founded_year | HQ Location |
Provider of transgenic rodent models and customized cell lines for preclinical development
|
|
| domain | founded_year | HQ Location |
Preclinical CRO services for CNS and orphan disorders are offered.
|
|
| domain | founded_year | HQ Location |
Preclinical CRO offering in vivo models and services for a wide range of therapeutic areas
|
|
| domain | founded_year | HQ Location |
Animal models are supplied for in-vivo analytical services.
|
|
| domain | founded_year | HQ Location |
Preclinical contract research organization offering standard GLP and non-GLP services
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Vivotecnia
When was Vivotecnia founded?
Vivotecnia was founded in 2002 and raised its 1st funding round 15 years after it was founded.
Where is Vivotecnia located?
Vivotecnia is headquartered in Tres Cantos, Spain. It is registered at Tres Cantos, Madrid, Spain.
What does Vivotecnia do?
Vivotecnia was founded in 2002 and is based in Tres Cantos, Spain. Preclinical contract research services are offered to biopharma companies, focusing on general toxicology, inhalation toxicology, genotoxicity, safety pharmacology, and efficacy studies. Animal species utilized include rats, mice, rabbits, dogs, guinea pigs, mini-pigs, and non-human primates. Operations emphasize safety and efficacy assessments in the biopharmaceutical sector.
Who are the top competitors of Vivotecnia?
Vivotecnia's top competitors include GenOway, PsychoGenics and Alpha Genesis.
What products or services does Vivotecnia offer?
Vivotecnia offers Toxicology Services, Biocides Testing, Cosmetics Safety Assessment, and Medical Device Testing.
Who are Vivotecnia's investors?
Vivotecnia has 3 investors. Key investors include European Union, Clave, and Mobius Corporate Venture Capital.